Search filters

List of works by Marco Rossi

A comparative effectiveness study of lipegfilgrastim in multiple myeloma patients after high dose melphalan and autologous stem cell transplant

scientific article published on 18 December 2019

A comprehensive safety evaluation of trabectedin and drug-drug interactions of trabectedin-based combinations.

scientific article

A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling.

scientific article published on 26 April 2011

A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells.

scientific article published on 14 January 2011

Anti-tumor Activity and Epigenetic Impact of the Polyphenol Oleacein in Multiple Myeloma

scientific article published on 16 July 2019

Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma

scientific article

Dendritic cells have the option to express IDO-mediated suppression or not

scientific article published on 01 March 2005

Enumeration of interleukin-10-positive B cells from peripheral blood of patients with chronic lymphocytic leukemia

scientific article published on 24 January 2014

Evidence of shared epitopic reactivity among independent B-cell clones in chronic lymphocytic leukemia patients.

scientific article published on 29 August 2016

From target therapy to miRNA therapeutics of human multiple myeloma: theoretical and technological issues in the evolving scenario.

scientific article published on September 2013

Immunologic microenvironment and personalized treatment in multiple myeloma.

scientific article published on 22 May 2013

In vitro and in vivo activity of a novel locked nucleic acid (LNA)-inhibitor-miR-221 against multiple myeloma cells.

scientific article published on 21 February 2014

In vivo anti-myeloma activity and modulation of gene expression profile induced by valproic acid, a histone deacetylase inhibitor.

scientific article

Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cells.

scientific article published on 22 May 2009

Inhibition of miR-21 restores RANKL/OPG ratio in multiple myeloma-derived bone marrow stromal cells and impairs the resorbing activity of mature osteoclasts

scientific article published on 24 June 2015

Intestinal toxicity during induction chemotherapy with cytarabine-based regimens in adult acute myeloid leukemia

scientific article

MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells

scientific article published on 21 November 2017

Mir-221/222 are promising targets for innovative anticancer therapy.

scientific article published on 9 March 2016

Molecular targets for the treatment of multiple myeloma.

scientific article published on September 2012

Mouse models of multiple myeloma: technologic platforms and perspectives.

scientific article

Network meta-analysis of randomized trials in multiple myeloma: efficacy and safety in relapsed/refractory patients

scientific article published on 27 February 2017

Non-Coding RNAs in Multiple Myeloma Bone Disease Pathophysiology

scientific article published on 09 September 2020

Peptide-loaded Langerhans cells, despite increased IL15 secretion and T-cell activation in vitro, elicit antitumor T-cell responses comparable to peptide-loaded monocyte-derived dendritic cells in vivo.

scientific article published on 25 February 2011

Plasmacytoid dendritic cells: do they have a role in immune responses after hematopoietic cell transplantation?

scientific article

Promises and Challenges of MicroRNA-based Treatment of Multiple Myeloma ⬇️

scientific article published on September 1, 2012

Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials

scientific article published on 03 July 2019

Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma

scientific article published on 18 February 2019

Role of gemcitabine-based combination therapy in the management of advanced pancreatic cancer: a meta-analysis of randomised trials

scientific article

Role of nucleophosmin in embryonic development and tumorigenesis

scientific journal article

Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo.

scientific article

Synthetic miR-34a mimics as a novel therapeutic agent for multiple myeloma: in vitro and in vivo evidence.

scientific article published on 3 October 2012

Targeting miR-21 inhibits in vitro and in vivo multiple myeloma cell growth

scientific article

The Non-Coding RNA Landscape of Plasma Cell Dyscrasias

scientific article published on 30 January 2020

Therapeutic vulnerability of multiple myeloma to MIR17PTi, a first-in-class inhibitor of pri-miR-17-92

scientific article published on 11 July 2018

Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma

scientific article published on 21 March 2019

miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma

scientific article published on 06 July 2020

miR-22 suppresses DNA ligase III addiction in multiple myeloma

scientific article published on 17 August 2018

miR-29b induces SOCS-1 expression by promoter demethylation and negatively regulates migration of multiple myeloma and endothelial cells

scientific article published on 25 September 2013

miR-29b negatively regulates human osteoclastic cell differentiation and function: implications for the treatment of multiple myeloma-related bone disease

scientific article published on July 2013

miR-29b sensitizes multiple myeloma cells to bortezomib-induced apoptosis through the activation of a feedback loop with the transcription factor Sp1

scientific article published on 29 November 2012

Paulina is supported by:

About Paulina

Help